My goal in this segment is to unlock both short-term and long-term growth in stocks that have just reported earnings. These stocks are specifically subject to enormous volatility, as earnings reports are seen (and rightfully so) as a significant display of a company’s progression in the market. What I offer you is an analysis of the economic well-being of the company, and whether I think the stock is a buy, hold or sell for either (or both) the short term or long term. To get used to the format of this segment, take a look at my last article on Tile Shop Holdings (NASDAQ:TTS).
After careful consideration, I have rated Air Lease Corp. (NYSE:AL) as a buy for the short term.
Air Lease Q4 Earnings
The airline industry has been doing extraordinarily well as of late, and investors have surely taken notice of Warren Buffett’s increase investment in the industry. Aircraft manufacturing companies like Boeing (NYSE:BA) are doing well, as well as airline companies such as like Delta Air Lines (NYSE:DAL) and United (NYSE:UAL). In this thriving industry, Air Lease is a company that will surely benefit and prosper. It is essentially the “middle man” in this industry, buying directly from Boeing, and then leasing aircraft to multiple airlines. Let’s take a look at Air Lease Corp.’s Q4 to get insight into how the company is faring in today’s economy.
Top 10 Growth Stocks To Watch Right Now: MEDIFAST INC(MED)
- [By Lisa Levin] Gainers
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday.
Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings.
Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744.
Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share.
Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results.
California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings.
Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results.
Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance.
Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46.
Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results.
Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance.
Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter.
Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36.
Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings.
Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result
- [By Lisa Levin]
Medifast, Inc. (NYSE: MED) shares were also up, gaining 25 percent to $124.60 after the company reported strong Q1 results and raised its FY18 guidance.
- [By Joseph Griffin]
MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.
Top 10 Growth Stocks To Watch Right Now: Buffalo Wild Wings Inc.(BWLD)
- [By Peter Graham]
A long term performance chart shows Dave & Busters Entertainmenttripling in valuebefore falling back whilesmall cap upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small capBuffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arbys Restaurant Group:
- [By Steve Symington]
That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.
Top 10 Growth Stocks To Watch Right Now: Nordstrom Inc.(JWN)
- [By Paul Ausick]
One bit of good news for Walmart is that its Sam’s Club warehouse stores scored an 80 to tie for third behind Costco Wholesale Corp. (NASDAQ: COST) at 83 and Nordstrom Inc. (NYSE: JWN) at 81.
- [By Stephan Byrd]
Nordstrom, Inc. (NYSE:JWN) insider Ken Worzel sold 13,703 shares of the company’s stock in a transaction on Wednesday, April 11th. The shares were sold at an average price of $48.97, for a total value of $671,035.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
- [By Adam Levine-Weinberg]
Nordstrom (NYSE:JWN) returned to earnings growth last quarter, as the reduced corporate tax rate helped the upscale retailer post a double-digit increase in earnings per share. Investors still dumped Nordstrom stock in after-hours trading on Thursday, punishing the company for weak comparable-store sales growth.
- [By Chris Lange]
Nordstrom Inc. (NYSE: JWN) released its fiscal first-quarter financial results after the markets closed on Thursday. The retailer said that it had $0.51 in earnings per share (EPS) on $3.56 billion in revenue, compared with consensus estimates from Thomson Reuters that called for $0.44 in EPS on revenue of $3.46 billion. The same period of last year reportedly had EPS of $0.37 and $3.35 billion in revenue.
Top 10 Growth Stocks To Watch Right Now: Intuitive Surgical Inc.(ISRG)
- [By Stephan Byrd]
Align Technology (NASDAQ: ALGN) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.
- [By ]
And stocks are following suit. Intuitive Surgical (NASDAQ: ISRG) for example, has been on strong, steady climb for the better part of a year.
- [By Sean Williams]
The VISE acronym stands for:
Visa (NYSE:V) Intuitive Surgical (NASDAQ:ISRG) Sirius XM Holdings (NASDAQ:SIRI) Electronic Arts (NASDAQ:EA)
Each of these four companies brings clear-cut competitive advantages to the table that should allow it to handily outperform the broader market (and the FANG stocks).
- [By Ethan Ryder]
These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:
Get Intuitive Surgical alerts:
Global Commercial Robotics Market 2018 by Key Players INTUITIVE SURGICAL INC , YASKAWA ELECTRIC … (themobileherald.com) Bullish or Bearish Territory: Intuitive Surgical, Inc. (ISRG) (nysestocks.review) Intuitive Surgical, Inc. (ISRG) -Price to Earnings Ratio Evaluation (P/E) (nasdaqfortune.com) Stock in Featured List: Intuitive Surgical, Inc. (ISRG) (stockquote.review) Intuitive Surgical (ISRG) Gains on Strength in Robotics (finance.yahoo.com)
A number of brokerages have recently weighed in on ISRG. Cantor Fitzgerald reissued a “buy” rating and issued a $490.00 price objective on shares of Intuitive Surgical in a report on Friday, January 26th. Zacks Investment Research lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Friday, January 26th. ValuEngine lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Piper Jaffray Companies reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Friday, January 26th. Finally, Vetr raised Intuitive Surgical from a “buy” rating to a “strong-buy” rating and set a $478.64 target price on the stock in a report on Monday, March 19th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. Intuitive Surgical presently has a consensus rating of “Buy” and a consensus target price of $457.59.
- [By Stephan Byrd]
Traders sold shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) on strength during trading on Monday. $62.49 million flowed into the stock on the tick-up and $93.11 million flowed out of the stock on the tick-down, for a money net flow of $30.62 million out of the stock. Of all stocks tracked, Intuitive Surgical had the 25th highest net out-flow for the day. Intuitive Surgical traded up $9.62 for the day and closed at $488.10
Top 10 Growth Stocks To Watch Right Now: TrueBlue Inc.(TBI)
- [By Stephan Byrd]
Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.
- [By Joseph Griffin]
Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.
- [By Logan Wallace]
Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.